Kristensen Søren Rud, Bech Mickael, Quentin Wilm
Manchester Centre for Health Economics, University of Manchester, UK; COHERE - Centre of Health Economics Research, Department of Business and Economics, University of Southern Denmark, Denmark.
COHERE - Centre of Health Economics Research, Department of Business and Economics, University of Southern Denmark, Denmark.
Health Policy. 2015 Mar;119(3):264-73. doi: 10.1016/j.healthpol.2014.12.009. Epub 2014 Dec 15.
Hospital readmissions receive increasing interest from policy makers because reducing unnecessary readmissions has the potential to simultaneously improve quality and save costs. This paper reviews readmission policies in Denmark, England, Germany and the United States (Medicare system). The suggested roadmap enables researchers and policy makers to systematically compare and analyse readmission policies. We find considerable differences across countries. In Germany, the readmission policy aims to avoid unintended consequences of the introduction of DRG-based payment; it focuses on readmissions of individual patients and hospitals receive only one DRG-based payment for both the initial and the re-admission. In Denmark, England and the US readmission policies aim at quality improvement and focus on readmission rates. In Denmark, readmission rates are publicly reported but payments are not adjusted in relation to readmissions. In England and the US, financial incentives penalise hospitals with readmission rates above a certain benchmark. In England, this benchmark is defined through local clinical review, while it is based on the risk-adjusted national average in the US. At present, not enough evidence exists to give recommendations on the optimal design of readmission policies. The roadmap can be a tool for systematically assessing how elements of other countries' readmission policies can potentially be adopted to improve national policies.
医院再入院问题越来越受到政策制定者的关注,因为减少不必要的再入院有可能同时提高医疗质量并节省成本。本文回顾了丹麦、英国、德国和美国(医疗保险系统)的再入院政策。所建议的路线图使研究人员和政策制定者能够系统地比较和分析再入院政策。我们发现各国之间存在相当大的差异。在德国,再入院政策旨在避免引入基于诊断相关分组(DRG)付费带来的意外后果;它侧重于个别患者的再入院情况,医院对于初次入院和再次入院仅收取一次基于DRG的费用。在丹麦、英国和美国,再入院政策旨在提高医疗质量,并侧重于再入院率。在丹麦,再入院率会公开报告,但付费不会因再入院情况而调整。在英国和美国,经济激励措施会惩罚那些再入院率高于某个基准的医院。在英国,这个基准是通过当地临床审查来确定的,而在美国则是基于风险调整后的全国平均水平。目前,尚无足够证据就再入院政策的最优设计提出建议。该路线图可以作为一种工具,用于系统评估如何有可能采用其他国家再入院政策的要素来改进本国政策。